Vismodegib

Chemical formula: C₁₉H₁₄Cl₂N₂O₃S  Molecular mass: 421.297 g/mol  PubChem compound: 24776445

Therapeutic indications

Vismodegib is indicated for:

Basal cell carcinoma

Population group: only adults (18 years old or older)

Vismodegib is indicated for the treatment of adult patients with:

  • symptomatic metastatic basal cell carcinoma.
  • locally advanced basal cell carcinoma inappropriate for surgery or radiotherapy.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Vismodegib is contraindicated in the following cases:

Pregnancy

Pregnancy

Lactation

Lactation

St. John (Hypericum perforatum)

Hypericum perforatum (St John's Wort)

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2019: ERIVEDGE Hard capsule
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈